Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin recepto…
Biotechnology
US, Seattle [HQ]
Filings / Resources
Link Index · Filing Reader · 10K/10QLoading may take some time.
SEC Filings
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-09-30
2018-06-30
2018-03-31
2017-09-30
2017-06-30
2017-03-31
2016-09-30
2016-06-30
2016-03-31
2015-09-30
2015-06-30
2015-03-31